We Are JPEO

The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) manages our nation’s investments in chemical, biological, radiological, and nuclear (CBRN) defense equipment and medical countermeasures.

The JPEO-CBRND leads, manages, and directs the acquisition, fielding and sustainment of CBRN sensors, protective equipment, medical countermeasures, specialized equipment for U.S. Special Forces, integration and information management systems, and defense enabling biotechnologies. The organization also works closely with various government agencies that need CBRN defense equipment. Learn more about the Joint Project Management Offices for CBRN Protection, CBRN Medical, CBRN Sensors, and CBRN SOF.

Learn more about the JPEO-CBRND

Our Mission

Protect the Joint Force from weapons of mass destruction by generating affordable capabilities.

Our Vision

A resilient Joint Force enabled to fight and win unencumbered by a chemical, biological, radiological, or nuclear environment; championed by innovative, agile, results-oriented acquisition professionals.

Partnering Benefits

 

Work with the JPEO-CBRND on providing solutions that protect the Joint Force and the Warfighter from weapons of mass destruction. Help us achieve our vision of a resilient Joint Force that's enabled to fight and win unencumbered by CBRN environments.

Innovative Contracting Experience iconInnovative Contracting Experience

Our Other Transactional Authority (OTA) agreements enable enhanced communications and support innovation. 

Agile Execution iconAgile Execution

We face a complex threat environment, so we need the partnership and support of industry and academia to help us innovate at the speed of relevancy for our current CBRN defense environments.

Share iconShare Your Latest Insights with Government

The JPEO-CBRND is eager to learn more about the latest innovations, capabilities and insights to help support the Joint Force and protect our Warfighters. 

Keep Current iconKeep Current on the CBRND Industrial Base’s Needs

Gain insight into the way ahead for our organization as well as our CBRND partners.

Modernize iconHelp Modernize the Joint Force 

Help establish and refine the long-term vision for CBRND capabilities.

Speed iconDevelopment at the Speed of Relevancy

Help the JPEO-CBRND tackle the R&D needs on the horizon and learn more about our “new start” programs here.

Featured Technologies

Joint Service General Purpose Mask (JSGPM)

Joint Service General Purpose Mask (JSGPM)

LEARN MORE

Next Generation Diagnostics System 1 (NGDS 1)

Next Generation Diagnostics System 1 (NGDS 1)

LEARN MORE

Nuclear, Biological, Chemical Reconnaissance Vehicle

Nuclear, Biological, Chemical Reconnaissance Vehicle (NBCRV)

LEARN MORE

News

American flags against a blue sky background

Biden Administration Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine as Additional Tool to Reduce Hospitalizations and Save Lives

News
Nov. 18, 2021

As part of its ongoing efforts to curb the pandemic, reduce hospitalizations, and save lives, the Biden...
Read More
Winners from the 2021 Defense Acquisition Workforce Award include LTC John Nuckols, Dr. Kevin Wingerd, JPEO-CBRND, U.S. Air Force, COVID-19 USTRANSCOM JUON TC-0003 Response, and U.S. Army, Operation Warp Speed and the JPEO-CBRND Medical Repurposing Team.

JPEO-CBRND Team and Partners Win Five Defense Acquisition Workforce Awards

News
Nov. 12, 2021

The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)...
Read More
Screenshot of CB Defense Today with guest Dr. Jason Roos

CB Defense Today with guest Dr. Jason Roos

News
Nov. 09, 2021

CB Defense Today is a quarterly recorded interview, where CBC Director, Dr. Eric L. Moore talks with other...
Read More
CBRND leadership speak on a panel at the 2021 CBRN Defense Conference

Key Federal Partners Gather to Plan, Act on Emerging CBRN Threats

News
Oct. 12, 2021

Efforts to prepare the U.S. military for a series of evolving threats to both the Warfighter and the nation...
Read More
Aerial photo of Ellume's new Fredrick, MD diagnostics manufacturing facility.

JPM CBRN Medical Provides Relief and Recovery in the Age of a Global Pandemic

News
Sep. 08, 2021

What do global pandemic relief efforts, the U.S. Army, and a local Maryland economy have in common? The answer...
Read More
Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

DOD Awards $64.6 Million Contract to SiO2 Medical Products to Increase Domestic Production Capacity of Pharmaceutical Vials

News
Jul. 29, 2021

IMMEDIATE RELEASE - On July 26, 2021, the Department of Defense (DOD), on behalf of and in coordination with...
Read More
American flags against a blue sky background

Biden Administration announces U.S. government procurement of Merck’s investigational antiviral medicine for COVID-19 treatment

News
Jun. 09, 2021

The Biden Administration today announced that the U.S. government will procure approximately 1.7 million...
Read More
COVID-19 vaccine rollout ongoing in U.S. Army Central footprint

DOD & HHS Announce DPA Title III Agreement With Retractable Technologies, Inc. to Expand Domestic Production Capacity for Low Dead-Space Safety Syringes and Needles

News
May. 24, 2021

As part of the national response to COVID-19, the Department of Defense (DOD), in coordination with the...
Read More
In the foreground a hand holding an orange sticker that says "I got my vaccine". In the background there are three medical personnel wearing personal protective equipment.

INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine

News
May. 10, 2021

INO-4800 was shown to be safe, well-tolerated and immunogenic in all age groups. Phase 2 results informed...
Read More
American flags against a blue sky background

Memorandum of Understanding for Acquisition Support Signed Between the Department of Defense and the Department of Health and Human Services

News
May. 26, 2021

On May 20, 2021, Deputy Secretary of Defense Kathleen Hicks and Deputy Secretary of Health and Human Services...
Read More
A servicemember sits in a yellow shirt in front of a table of red and blue testing vials. Covi

Biden Administration secures supply of new COVID-19 therapeutic treatment

News
Feb. 26, 2021

FOR IMMEDIATE RELEASE - The Biden Administration announced today that it has secured a supply of a recently...
Read More
The appearance of hyperlinks does not constitute endorsement by the JPEO-CBRND of non-U.S. Government sites or the information, products, or services contained therein. Although the JPEO-CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.